OneMedNet (NASDAQ:ONMD – Get Free Report) and Snap (NYSE:SNAP – Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
Institutional & Insider Ownership
1.0% of OneMedNet shares are owned by institutional investors. Comparatively, 47.5% of Snap shares are owned by institutional investors. 46.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares OneMedNet and Snap’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| OneMedNet | -205.96% | N/A | -355.73% |
| Snap | -7.76% | -20.72% | -6.09% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| OneMedNet | $1.36 million | 35.90 | -$2.80 million | ($0.07) | -13.36 |
| Snap | $5.93 billion | 1.71 | -$460.49 million | ($0.27) | -22.27 |
OneMedNet has higher earnings, but lower revenue than Snap. Snap is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
OneMedNet has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, Snap has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations for OneMedNet and Snap, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
| Snap | 3 | 20 | 5 | 1 | 2.14 |
Snap has a consensus target price of $8.16, suggesting a potential upside of 35.66%. Given Snap’s stronger consensus rating and higher possible upside, analysts clearly believe Snap is more favorable than OneMedNet.
Summary
Snap beats OneMedNet on 8 of the 15 factors compared between the two stocks.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
About Snap
Snap Inc. operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. It also provides Spectacles, an eyewear product that connects with Snapchat and captures photos and video from a human perspective; and advertising products, including AR ads and Snap ads comprises a single image or video ads, collection ads, dynamic ads, story ads, and commercials. The company was formerly known as Snapchat, Inc. and changed its name to Snap Inc. in September 2016. Snap Inc. was founded in 2010 and is headquartered in Santa Monica, California.
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
